Deferasirox
16 NDCs across 9 manufacturers|16 Generic,0 Brand
Deferasirox is used to treat iron overload, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 2, 2005, and the first generic was approved Jan 26, 2016. FDA's Orange Book lists 84 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Deferasirox across 20,000 claims for 3,918 beneficiaries.
Deferasirox is available as 16 NDCs from 9 manufacturers (16 generic, 0 brand), with NADAC prices from $0.88 to $2.10 per EA — the most expensive product costs about 2.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
16G / 0B
Manufacturers
9
competing in market
Price Spread
$0.88 – $2.10
per EA
7d Activity
avg -6.9% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Alembic Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Iron Chelator class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing DEFERASIROX(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DEFERASIROX 360 MG TABLET | $2.1034 per EA | — |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 360 MG TABLET | $1.2475 per EA | -6.90% |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
DEFERASIROX 180 MG TABLET | $0.8750 per EA | — |
Frequently Asked Questions
What is Deferasirox used to treat?
Deferasirox is used to treat iron overload, per the National Library of Medicine's MED-RT classification.
When did Deferasirox become available as a generic?
FDA approved the first generic Deferasirox (ANDA) on Jan 26, 2016. The Orange Book currently lists 84 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Deferasirox?
In 2024, Medicare Part D spent $41 million on Deferasirox across 20,000 claims for 3,918 beneficiaries.
How many Deferasirox products are on the market?
The Deferasirox drug market contains 16 NDCs from 9 manufacturers — 16 generic and 0 brand products.
What is the price range for Deferasirox?
NADAC reference prices for Deferasirox range from $0.8750 to $2.1034 per EA — the most expensive product costs about 2.4× the cheapest.
Which manufacturers make Deferasirox?
9 manufacturers list Deferasirox in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (2), Xiromed LLC (2), Zydus Pharmaceuticals (USA) Inc. (2), Camber Pharmaceuticals Inc. (2), NorthStar Rx LLC (2).
How has the price of Deferasirox changed recently?
Over the past 7 days, 0 Deferasirox NDCs rose and 8 fell, with a market-wide average change of -6.9%.